New cancer clinical trial: Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer

Published on: January 25, 2019 at 12:00PM
Conditions:   Advanced Malignant Neoplasm;   Autoimmune Disease;   Crohn Disease;   Dermatomyositis;   Inflammatory Bowel Disease;   Metastatic Malignant Neoplasm;   Multiple Sclerosis;   Rheumatoid Arthritis;   Sjogren Syndrome;   Systemic Lupus Erythematosus;   Systemic Scleroderma;   Ulcerative Colitis;   Unresectable Malignant Neoplasm
Intervention:   Biological: Nivolumab
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
http://bit.ly/2HwI8fh